Brief: Sernova Announces Positive Updated Phase 1/2 Clinical Data On Cell Pouch System
06/06/2022 22:22
June 6 (Reuters) - Sernova Corp SVA.TO :
* SERNOVA ANNOUNCES POSITIVE UPDATED PHASE 1/2 CLINICAL DATA
ON
CELL POUCH SYSTEM™ AT AMERICAN DIABETES ASSOCIATION 82ND
SCIENTIFIC SESSIONS 2022
* SERNOVA CORP - SURGICAL IMPLANTATION OF CELL POUCH WAS
FOUND TO
BE GENERALLY WELL TOLERATED WITH A FAVORABLE SAFETY PROFILE
Source text for Eikon: ID:nGNXbCCnVQ
Further company coverage: SVA.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sernova Biotherapeutics
See all newsBrief: Seraxis And Sernova Announce Appointment Of Former FDA Medical Officer Dr. Patricia Beaston As Chief Medical Officer Of Seraxis And Post Merger Betanova Biotherapeutics
Brief: Sernova Appoints Jonathan Rigby As Interim Chair
Brief: Sernova Biotherapeutics Provides Positive Interim Data From Ongoing Phase 1/2 Clinical Trial Of Cell Pouch Bio-Hybrid Organ In Patients Living With Type 1 Diabetes
Brief: Sernova Biotherapeutics Secures $4 Million Loan To Further Advance Its Clinical Development Plans
Brief: Sernova Biotherapeutics Inc Study Is On Track To Meet Key Clinical Trial Endpoints